Evidence map›Paper›PMID 19433343›Full record

ArticleEuropean journal of medicinal chemistry2009

Synthesis, antiviral activity, and stability of nucleoside analogs containing tricyclic bases.

Franck Amblard, Emilie Fromentin, Mervi Detorio, Alexander Obikhod, Kimberly L Rapp, Tamara R McBrayer, Tony Whitaker, Steven J Coats, Raymond F Schinazi

Abstract read
In one paragraph

Article in European journal of medicinal chemistry, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact, top 86% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Franck AmblardDepartment of Pediatrics, Center for AIDS Research, Veterans Affairs Medical Center, Laboratory of Biochemical Pharmacology, Emory University School of Medicine, Atlanta, GA 30033, USA.
Emilie Fromentin
Mervi Detorio
Alexander Obikhod
Kimberly L Rapp
Tamara R McBrayer
Tony Whitaker
Steven J Coats
Raymond F Schinazi
Emory University · USJohns Hopkins University Center for AIDS Research

Funding

Virology and Molecular Biomarkers CoreP30AI050409 · NIAID · EMORY UNIVERSITY · PI Carlos del Rio · 2002 to 2026
$74.0M
Rational Design of NRTI for Drug Resistant HIV-1R01AI071846 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI MELLORS, JOHN W · 2007 to 2010
$2.9M
NUCLEOSIDES WITH DUAL ANTI-HIV AND HBV ACTIVITYR37AI041980 · NIAID · EMORY UNIVERSITY · PI SCHINAZI, RAYMOND FELIX · 2000 to 2009
$2.1M
NUCLEOSIDES WITH DUAL ANTIHIV AND HBV ACTIVITYR01AI041980 · NIAID · EMORY UNIVERSITY · PI SCHINAZI, RAYMOND F. · 1997 to 1999
–
NIAID NIH HHS 5P30-AI-50409NIAID NIH HHS 5R01-AI-071846NIAID NIH HHS 5R37-AI-041980NIAID NIH HHS P30 AI050409NIAID NIH HHS R01 AI041980NIAID NIH HHS R01 AI071846NIAID NIH HHS R37 AI041980
6 · The paper itself

Abstract

A series of 3,9-dihydro-9-oxo-5H-imidazo[1,2-A]purine nucleosides (tricylic nucleosides) were synthesized from 9-[4-alpha-(hydroxymethyl)cyclopent-2-ene-1-alpha-yl]guanine (CBV) 5, (-)-beta-D-(2R,4R)-1,3-dioxolane-guanosine (DXG) 6, 3'-azido-3'-deoxy-guanosine (AZG) 7, and 2'-C-methylguanosine 8. Their in vitro activity against HIV and HCV was evaluated and correlated to their ability to degrade to their purine counterpart.

Indexed as

AnimalsAntiviral AgentsCells, CulturedCell SurvivalChlorocebus aethiopsHepacivirusHerpesvirus 1, HumanHIVHumansNucleosidesVero CellsAntiviral AgentsNucleosides

Identifiers

PMID19433343
PMCPMC3423956
OpenAlexW2091165675

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.